What is UroGen Pharma's common stock?

UroGen Pharma (URGN) reported common stock of $134K in Q1 2026.

How has UroGen Pharma's common stock changed year-over-year?

UroGen Pharma's common stock increased by 6.3% year-over-year, from $126K to $134K.

What is the long-term trend for UroGen Pharma's common stock?

Over 5 years (2020 to 2025), UroGen Pharma's common stock has grown at a 17.3% compound annual growth rate (CAGR), from $60K to $133K.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

UroGen Pharma URGN Common Stock

Common Stock at other companies

Bristol-Myers SquibbBMY

$292M0.0%

ImmunityBio, Inc.IBRX

1.7B+22.2%

Tyra Biosciences, Inc.TYRA

$6K+20.0%

CG OncologyCGON

$9K+12.5%

Nuvation BioNUVB

$1.43B+3.5%

ImmunomeIMNM

$11K+22.2%

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.73B+71.7%

Enterprise value$1.81B+80.9%

P/S12.3×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Reported directly by UroGen Pharma in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's common stock?: UroGen Pharma (URGN) reported common stock of $134K in Q1 2026.
How has UroGen Pharma's common stock changed year-over-year?: UroGen Pharma's common stock increased by 6.3% year-over-year, from $126K to $134K.
What is the long-term trend for UroGen Pharma's common stock?: Over 5 years (2020 to 2025), UroGen Pharma's common stock has grown at a 17.3% compound annual growth rate (CAGR), from $60K to $133K.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).